Immune function of colon cancer associated miRNA and target genes

被引:3
|
作者
Han, Lu [1 ,2 ]
Chen, Shiyun [1 ,2 ]
Luan, Zhe [3 ]
Fan, Mengjiao [1 ,2 ]
Wang, Yanrong [1 ,2 ]
Sun, Gang [3 ]
Dai, Guanghai [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Dept Oncol, Med Ctr 5, Beijing, Peoples R China
[2] Med Sch Chinese PLA, Beijing, Peoples R China
[3] Chinese Peoples Liberat Army Gen Hosp, Dept Gastroenterol & Hepatol, Med Ctr 1, Beijing, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
关键词
colon cancer; miRNA; prognosis; immune cell; immune microenvironment; COLORECTAL-CANCER; RECEPTOR; POLARIZATION; MACROPHAGES; PROGRESSION; EXPRESSION; MIR-146A; MIR-21; APELIN; CELLS;
D O I
10.3389/fimmu.2023.1203070
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IntroductionColon cancer is a complex disease that involves intricate interactions between cancer cells and theimmune microenvironment. MicroRNAs (miRNAs) have recently emerged as critical regulators of gene expression in cancer, including colon cancer. There is increasing evidence suggesting that miRNA dysregulation plays a crucial role in modulating the immune microenvironment of intestinal cancer. In particular, miRNAs regulate immune cell activation, differentiation, and function, as well as cytokine and chemokine production in intestinal cancer. It is urgent to fully investigate the potential role of intestinal cancer-related miRNAs in shaping the immune microenvironment. MethodsTherefore, this paper aims to identify miRNAs that are potentially associated with colon cancer and regulate a large number of genes related to immune function. We explored the role of these genes in colon cancer patient prognosis, immune infiltration, and tumor purity based on data of 174 colon cancer patients though convolutional neural network, survival analysis and multiple analysis tools. ResultsOur findings suggest that miRNA regulated genes play important roles in CD4 memory resting cells, macrophages.M2, and Mast cell activated cells, and they are concentrated in the cytokinecytokine receptor interaction pathway. DiscussionOur study enhances our understanding of the underlying mechanisms of intestinal cancer and provides new insights into the development of effective therapies. Additionally, identification of miRNA biomarkers could aid in diagnosis and prognosis, as well as guide personalized treatment strategies for patients with intestinal cancer.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Global Analysis of miRNA Target Genes in Colon Rectal Cancer
    Pradhan, Meeta
    Ledford, Lakenvia
    Pandit, Yogesh
    Palakal, Mathew
    2010 IEEE INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICINE, 2010, : 341 - 345
  • [2] Bioinformatics Analysis of Prognostic miRNA Signature and Potential Critical Genes in Colon Cancer
    Chen, Weigang
    Gao, Chang
    Liu, Yong
    Wen, Ying
    Hong, Xiaoling
    Huang, Zunnan
    FRONTIERS IN GENETICS, 2020, 11
  • [3] Identification of Hypoxia-Associated Signature in Colon Cancer to Assess Tumor Immune Microenvironment and Predict Prognosis Based on 14 Hypoxia-Associated Genes
    Chen, Peng
    Li, Zhongxin
    Liang, Yulong
    Wei, Ming
    Jiang, Haibo
    Chen, Shihao
    Zhao, Zengren
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2023, 16 : 2503 - 2518
  • [4] Development of a novel necroptosis-associated miRNA risk signature to evaluate the prognosis of colon cancer patients
    Huang, Yang
    Zou, Yuanyuan
    Xiong, Qiru
    Zhang, Chao
    Maria Sayagues, Jose
    Shelat, Vishal G.
    Wang, Xingyu
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (24)
  • [5] Identification and validation of xenobiotic metabolism-associated prognostic signature based on five genes to evaluate immune microenvironment in colon cancer
    Wen, Lina
    Han, Zongqiang
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 12 (06) : 2788 - +
  • [6] Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of colorectal cancer
    Ge, Penglei
    Wang, Weiwei
    Li, Lin
    Zhang, Gong
    Gao, Zhiqiang
    Tang, Zhe
    Dang, Xiaowei
    Wu, Yang
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 118
  • [7] BRAF Mutation as a Potential Therapeutic Target for Checkpoint Inhibitors: A Comprehensive Analysis of Immune Microenvironment in BRAF Mutated Colon Cancer
    Cen, Shuyi
    Liu, Kun
    Zheng, Yu
    Shan, Jianzhen
    Jing, Chao
    Gao, Jiale
    Pan, Hongming
    Bai, Zhigang
    Liu, Zhen
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [8] An Integrated miRNA-lncRNA Signature Predicts the Survival of Stage II Colon Cancer
    Wang, Xiao-Jie
    Zeng, Bing
    Lin, Shuangming
    Chen, Min
    Chi, Pan
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2019, 49 (06) : 730 - 739
  • [9] A signature of immune function genes associated with recurrence-free survival in breast cancer patients
    Ascierto, Maria Libera
    Kmieciak, Maciej
    Idowu, Michael O.
    Manjili, Rose
    Zhao, Yingdong
    Grimes, Margaret
    Dumur, Catherine
    Wang, Ena
    Ramakrishnan, Viswanathan
    Wang, Xiang-Yang
    Bear, Harry D.
    Marincola, Francesco M.
    Manjili, Masoud H.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 131 (03) : 871 - 880
  • [10] A Prognostic Ferroptosis-Related lncRNA Model Associated With Immune Infiltration in Colon Cancer
    Lu, Jianzhong
    Tan, Jinhua
    Yu, Xiaoqing
    FRONTIERS IN GENETICS, 2022, 13